• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Abhydrolase domain-containing protein 14B (ABHD14B)

ACP13786

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13786 Target NameABHD14B
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-210Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96IU4
Background Information
  • Uniprot Id

    Q96IU4

  • Target Species

    Human

  • Target Name

    ABHD14B

  • Target Full Name

    Putative protein-lysine deacylase ABHD14B

  • Target Function

    Has hydrolase activity towards p-nitrophenyl butyrate (in vitro). May activate transcription.

  • Target Subcellular Location

    Cytoplasm. Nucleus. Note=Predominantly cytoplasmic.

  • Target Protein Families

    AB hydrolase superfamily, ABHD14 family

  • Target Tissue Specificity

    Ubiquitous. Detected in spleen, thymus, prostate, testis, ovary, small intestine, colon, peripheral blood leukocyte, heart, placenta, lung, liver, skeletal muscle, pancreas and kidney.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    ABHD14B; ABHEB_HUMAN; Abhydrolase domain containing 14B; Abhydrolase domain containing protein 14B; Abhydrolase domain-containing protein 14B; CCG1 interacting factor B; CCG1-interacting factor B; Cell cycle gene 1 interacting factor B; CIB; MGC15429; OTTHUMP00000212469

Inquire Recombinant Human Abhydrolase domain-containing protein 14B (ABHD14B) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification